Evidence map›Paper›PMID 38027647›Full record

ArticleHeliyon2023

Yang Luo, Renhao Ni, Xiaojun Jin, Peipei Feng, Chenyi Dai, Lingjing Jiang, Pingping Chen, Lu Yang, Yabin Zhu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yang LuoHealth Science Center, Ningbo University, Ningbo, 315211, China.
Renhao NiHealth Science Center, Ningbo University, Ningbo, 315211, China.
Xiaojun JinHealth Science Center, Ningbo University, Ningbo, 315211, China.
Peipei FengNingbo Institute of Innovation for Combined Medicine and Engineering, Ningbo Medical Centre Lihuili Hospital, Ningbo, 315000, China.
Chenyi DaiHealth Science Center, Ningbo University, Ningbo, 315211, China.
Lingjing JiangHealth Science Center, Ningbo University, Ningbo, 315211, China.
Pingping ChenNingbo Eye Hospital, Ningbo, 315042, China.
Lu YangThe First Affiliated Hospital of Ningbo University, Ningbo, 315010, China.
Yabin ZhuHealth Science Center, Ningbo University, Ningbo, 315211, China.
Ningbo University · CNAnyang Eye Hospital · CNNingbo Medical Center Lihuili Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FOXD1, a new member of the

Indexed as

FOXD1Patient survivalPrognostic modelTreatment sensitivityUveal melanoma

Identifiers

PMID38027647
PMCPMC10651470
OpenAlexW4387873452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.